- Home
- PLUR
PLUR
Pluri Inc.
as of 06-04-2026 1:28pm EST
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
| Founded: | 2001 | Country: | Israel |
| Employees: | N/A | City: | HAIFA |
| Market Cap: | 36.3M | IPO Year: | 2001 |
| Target Price: | $12.00 | AVG Volume (30 days): | 15.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.90 | EPS Growth: | 10.78 |
| 52 Week Low/High: | $2.22 - $5.96 | Next Earning Date: | 05-08-2026 |
| Revenue: | $1,336,000 | Revenue Growth: | 309.82% |
| Revenue Growth (this year): | 97.38% | Revenue Growth (next year): | 293.97% |
| P/E Ratio: | -1.25 | Index: | N/A |
| Free Cash Flow: | -19829000.0 | FCF Growth: | N/A |
Compare PLUR vs Leading Stocks
See how PLUR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PLUR Pluri Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.